Woodline Partners’s Tevogen Inc. Common Stock TVGN Stock Holding History

Woodline Partners’s Portfolio TVGN Stock Details TVGN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q1	–	Sell	-585	Closed	-$302K	–	797
2022 Q4	$302K	Hold	585	–	–	﹤0.01%	653
2022 Q3	$296K	Buy	585 +85	+17%	+$42.9K	﹤0.01%	620
2022 Q2	$250K	Hold	500	–	–	﹤0.01%	601
2022 Q1	$250K	Buy	+500	New	+$249K	﹤0.01%	540

Other funds holding TVGN

CCP

Corbin Capital Partners New York $61.3M AUM 53.03% 1-Year Est. Return

FCM

FourWorld Capital Management New York $196M AUM 42.39% 1-Year Est. Return

Cantor Fitzgerald New York $6.78B AUM 29.01% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Woodline Partners's TVGN Position: Q1 2023 in Review

Woodline Partners sold out of Tevogen Inc. Common Stock (TVGN) in Q1 2023, closing a stake of 585 shares — an estimated $302K sold.

Woodline Partners first reported a position in TVGN in Q1 2022 and held it in 4 quarters. The position peaked at $302K in Q4 2022. 4 funds tracked by Wall St. Rank hold TVGN as of Q1 2023.

Woodline Partners reported no remaining Tevogen Inc. Common Stock position as of Q1 2023 after selling out during the quarter.
Woodline Partners sold 585 Tevogen Inc. Common Stock shares in Q1 2023, an estimated $302K.
Woodline Partners first reported a position in Tevogen Inc. Common Stock in Q1 2022 and held it in 4 quarters.
Woodline Partners's Tevogen Inc. Common Stock position peaked at $302K in Q4 2022.
4 funds tracked by Wall St. Rank held Tevogen Inc. Common Stock as of Q1 2023.

Based on Woodline Partners's 13F filing for Q1 2023, filed 15 May 2023.